Clinical Research Directory
Browse clinical research sites, groups, and studies.
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
Sponsor: Universitaire Ziekenhuizen KU Leuven
Summary
The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical assessments as part of diagnostic evaluation.
Official title: The Diagnostic Validity and Clinical Impact of Blood-based Biomarkers for the Diagnosis of Alzheimer's Disease at the Primary Care Level.
Key Details
Gender
All
Age Range
55 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2026-05-26
Completion Date
2038-04
Last Updated
2026-06-24
Healthy Volunteers
Yes
Conditions
Interventions
ptau217
Quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma.
Locations (1)
UZ Leuven/KU Leuven
Leuven, Belgium